热门资讯> 正文

永旺Bizerma宣布任命首席执行官

2025-04-22 04:34

AEON Biopharma (NYSE:AEON) announced the appointment of Rob Bancroft as president and chief executive officer, effective April 29, 2025.
Bancroft will also join AEON’s board of directors.
Prior to joining AEON, Bancroft served as general manager of the Therapeutics business at Revance Therapeutics.
Source: Press release

More on AEON Biopharma

AEON Biopharma shares plunge as it announces reverse stock split
AEON Biopharma receives NYSE non-compliance notice
Financial information for AEON Biopharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。